57 results on '"C. Rouger"'
Search Results
2. Bioactivity and Secondary Metabolome Profiling of Marine Fungi Associated with the Seagrass Zostera marina
- Author
-
Michael Marner, Antje Labes, C Rouger, LE Petersen, and Deniz Tasdemir
- Subjects
Seagrass ,biology ,Chemical engineering ,Botany ,Metabolome ,Zostera marina ,biology.organism_classification ,Marine fungi - Published
- 2017
- Full Text
- View/download PDF
3. Mucormycoses post-traumatiques à Lichtheimia corymbifera : à propos de 3 cas
- Author
-
D. Toubas, Antoine Huguenin, C. Strady, D. Lambert, X. Ohl, V. Noel, C. Rouger, Alexandre Mzabi, Isabelle Villena, Firouzé Bani-Sadr, S. Diallo, and C. Nerot
- Subjects
Gynecology ,Posaconazole ,medicine.medical_specialty ,Infectious Diseases ,Cutaneous mucormycosis ,business.industry ,Lichtheimia corymbifera ,Mucormycosis ,medicine ,medicine.disease ,business ,medicine.drug - Abstract
Resume Nous rapportons 3 observations de mucormycoses cutanees post-traumatiques a Lichtheimia corymbifera , dont 2 survenues apres un traumatisme majeur en milieu agricole. La prise en charge des mucormycoses post-traumatiques repose sur une large excision des tissus infectes, associee a un traitement antifongique, prescrit le plus rapidement possible. L’amphotericine B liposomale est le traitement recommande en premiere ligne. Le posaconazole a ete peu evalue. Nos trois patients ont beneficie d’un debridement chirurgical associe a un traitement antifongique par amphotericine B liposomale dans tous les cas, avec relais par posaconazole dans 2 cas. La duree du traitement antifongique n’est pas definie. Tous nos patients ont recu un traitement de 5 semaines, avec une evolution favorable.
- Published
- 2014
- Full Text
- View/download PDF
4. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - 'En route for eradication'?
- Author
-
P. Geneau de Lamarlière, F. Daoud, C. Etienne, Pascal Pugliese, Thomas Huleux, N. Oran, C. Guglielminotti, V. Le Moing, L. Larmet, J.M. Jacquet, P. Delobel, D. Lebrun, Olivier Lortholary, S. Gallie, Elisabeth Botelho-Nevers, E. de Mautort, T. Jovelin, A.S. Ritleng, S. Ferrando, G. Dos Santos, V. Corbin, C. Lions, S. Bouchez, C. Jacomet, V. Guéripel, A. Foltzer, T.H. Huleux, J. Cottalorda, M. Besnier, O. Baud, E. Puntis, Martine Valette, D. Lebeaux, I. Poizot-Martin, M. Ouka, M.J. Soavi, G. Cessot, C. Duvivier, M. Priester, D. Rey, I. Kmiec, B. Henry, Marc-Antoine Valantin, Florence Ader, M.L. Casanova, M. Marcel, F. Touam, David Rey, H. Hüe, S. Degroodt, B. Riff, N. Atoui, D. Garipuy, C. Brochier, Christine Jacomet, Ch. Allienne, C. Aumeran, Nathalie B. Viget, Pierre Pradat, R. Ouissa, M.A. Valantin, S. Brégigeon, S. Pineau, I. Jacquet, Y. N'Guyen, B. Rozé, A. Joulie, L. Hustache-Mathieu, P. Morineau, O. Aubry, Sylvie Pillet, J. Reynes, E. Rosenthal, C. Psomas, Claudine Duvivier, M. Mularczyk, Thomas Perpoint, A. Montoya-Ferrer, V. Baclet, V. Faucherre, Amandine Gagneux-Brunon, F. Ajana, E. Billaud, J. Durant, C. Cheneau, A. Rodallec, Christine Katlama, M. Porte, Bruno Hoen, Olivier Lesens, A. Debard, F. Bani-Sadr, Ph. Choisy, Jacques Reynes, S. Casanova, L. Fagour, S. Pierre-François, S. Sausse, Clotilde Allavena, C. Blanco-Betancourt, I. Schlienger, O. Faucher, C. Bernaud, André Boibieux, C. Migault, H. Laurichesse, C. Merle De Boever, Laurent Cotte, Eric Billaud, Caroline Charlier, E. Cua, Christian Chidiac, M.C. Thiebaut-Drobacheff, J. Lippmann, V. Gendrin, Catherine Chirouze, E. Ressiot, E. Demonchy, K. Risso, V. Rio, Isabelle Poizot-Martin, Patrick Miailhes, H. Laroche, François Raffi, I. Lamaury, M. Pircher, A. Gergely, C. Brunet, I. Perbost, Lise Cuzin, H. Melliez, M.F. Lutz, C. Debreux, C. Augustin-Normand, Antoine Cheret, Guillaume Martin-Blondel, N. Hall, M.L. Batard, Th. Huleux, A. Galinier, J.L. Berger, B. Marchou, C. Fourcade, Frédéric Lucht, Firouzé Bani-Sadr, B. Bonnet, E. Aissi, I. Lepain, D. Boutoille, M. Partisani, P. Fischer, André Cabié, C. Ceppi, Céline Cazorla, M.J. Ducassou, R. Césaire, M. Carta, C. Bernard-Henry, Rodolphe Garraffo, A. Cabié, L. Cuzin, N. Mrozek, Evelyne Braun, F. Bozon, A. De Monte, I. Alcaraz, C. Biron, C. Louisin, Claire Aguilar, C. Delpierre, A. Ivanova, V. Mondain, M. Hentzien, Paul-Henri Consigny, P. Point, K. Saune, C. Rouger, J.G. Fuzibet, J. Koffi, Anne Frésard, C. Longuet, E. André-Garnier, S. Wehrlen-Pugliese, M. Alvarez, M Orticoni, B. Hoen, N. Biezunski, A. Naqvi, Tristan Ferry, B. Prouvost-Keller, A. Frésard, V. Reliquet, P.M. Roger, J. Courjon, F. Biron, R. Agher, M. Vidal, C. Rouzaud, F. Najioullah, A. Meybeck, D. Lambert, L. Cotte, Fanny Lanternier, Alain Makinson, S. Vandame, Laurent Hustache-Mathieu, D. Coban, S. Abel, P. Dellamonica, V. Obry-Roguet, Hospices Civils de Lyon (HCL), Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service Universitaire des Maladies Infectieuses et du Voyageur [Tourcoing], Centre Hospitalier Tourcoing, Service de Maladies Infectieuses [Nice], Service d'immuno-hématologie clinique (CISIH), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Université Montpellier 1 (UM1)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Service des maladies infectieuses [Nantes], Unité des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre de Recherche en Cancérologie de Lyon (CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Coordination régionale de la lutte contre le virus de l’immunodéficience humaine ( COREVIH [Toulouse]), Recherches Translationnelles sur le VIH et les maladies infectieuses (TransVIHMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche pour le Développement (IRD)-Université Montpellier 1 (UM1)-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Universtié Yaoundé 1 [Cameroun]-Université de Montpellier (UM), Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), CHU Clermont-Ferrand, Centre d'infectiologie Necker-Pasteur [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Infection à VIH, réservoirs, diversité génétique et résistance aux antirétroviraux (ARV) (EA 7327), Université Paris Descartes - Paris 5 (UPD5), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), service de maladies infectieuses CHU J Minjoz Besancon, Hôpital Jean Minjoz, Service des Maladies Infectieuses et Tropicales [Point-à-Pitre], CHU Pointe-à-Pitre/Abymes [Guadeloupe], Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane), CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles et de la Guyane (UAG), Service de Maladies Infectieuses et Tropicales [Fort-de-France, Martinique], CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Maladies infectieuses et tropicales dans la Caraïbe (MAITC), CHU Pointe-à-Pitre/Abymes [Guadeloupe] -CHU de la Martinique [Fort de France]-Université des Antilles (UA), Service de Maladies Infectieuses et Tropicales [Hôpital de la Croix-Rousse - HCL], Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université des Antilles et de la Guyane (UAG)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], Maladies infectieuses et tropicales dans la Caraïbe (MAITC EA 4537), roussel, pascale, Service de Maladies Infectieuses et Tropicales [CHU Pitié-Salpêtrière], Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut Pasteur [Paris], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Université des Antilles (UA)-CHU de la Martinique [Fort de France], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, and Institut Pasteur [Paris]-CHU Necker - Enfants Malades [AP-HP]
- Subjects
Male ,Epidemiology ,Hepacivirus ,[SDV]Life Sciences [q-bio] ,HIV Infections ,medicine.disease_cause ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,030212 general & internal medicine ,Chronic ,ComputingMilieux_MISCELLANEOUS ,biology ,Coinfection ,Incidence (epidemiology) ,virus diseases ,Hepatitis C ,Middle Aged ,3. Good health ,[SDV] Life Sciences [q-bio] ,Infectious Diseases ,Treatment Outcome ,Cohort ,HCV ,030211 gastroenterology & hepatology ,Female ,France ,Antibody ,Microbiology (medical) ,medicine.medical_specialty ,Genotype ,Hepatitis C virus ,Antiviral Agents ,03 medical and health sciences ,Internal medicine ,Treatment uptake ,medicine ,Humans ,Direct acting antiviral agent ,DAA ,business.industry ,HIV ,Hepatitis C Antibodies ,Hepatitis C, Chronic ,medicine.disease ,biology.organism_classification ,digestive system diseases ,Immunology ,biology.protein ,business - Abstract
International audience; Direct-Acting Antivirals (DAAs) opened a new era in HCV treatment. We report the impact of HCV treatment in French HIV-HCV coinfected patients. METHODS: All HIV-HCV patients from the Dat'AIDS cohort followed between 2012 and 2015 were included. HCV status was defined yearly as naive, spontaneous cure, sustained virological response (SVR12), failure or reinfection. RESULTS: Among 32,945 HIV-infected patients, 15.2% were positive for anti-HCV antibodies. From 2012 to 2015, HCV incidence rate increased from 0.35%PY to 0.69%PY in MSM, while median incidence was 0.08%PY in other patients. Median reinfection rate was 2.56%PY in MSM and 0.22%PY in other patients. HCV treatment initiation rate rose from 8.2% in 2012 to 29.6% (48.0% in pre-treated patients vs 22.6% in naïve patients). SVR12 rate increased from 68.7% to 95.2%. By the end of 2015, 62.7% of the patients were cured either spontaneously or following SVR. CONCLUSIONS: HCV treatment dramatically increased in HIV-HCV patients in France from 2012 to 2015 resulting in HCV cure in nearly two-thirds of the patients in this cohort. Combined with a declining HCV prevalence, the prevalence of active HCV infection among HIV patients will drastically decrease in the forthcoming years.
- Published
- 2016
- Full Text
- View/download PDF
5. [Post-traumatic mucormycosis due to Lichtheimia corymbifera: three case reports]
- Author
-
D, Lambert, C, Nerot, A, Huguenin, S, Diallo, A, Mzabi, X, Ohl, V, Noel, C, Rouger, C, Strady, I, Villena, F, Bani-Sadr, and D, Toubas
- Subjects
Adult ,Male ,Immunocompromised Host ,Antifungal Agents ,Adolescent ,Debridement ,Dermatomycoses ,Humans ,Mucormycosis ,Wounds and Injuries ,Absidia ,Middle Aged - Abstract
We report 3 cases of post-traumatic cutaneous mucormycosis caused by Lichtheimia corymbifera, two of them occurring after a farm working accident. Management of post-traumatic mucormycoses consists of a wide excision of the infected tissue, combined with immediate antifungal therapy. Liposomal amphotericin B is the recommended first line treatment. Few studies have evaluated the efficacy of posaconazole. All 3 patients received a surgical debridement and liposomal amphotericin B, which was followed by posaconazole in 2 cases. The duration of the antifungal treatment is not yet well defined. All three patients received a treatment of five weeks with a favorable outcome.
- Published
- 2014
6. [A false alopecia areata]
- Author
-
C, Rouger, Y, N'Guyen, and F, Bani-Sadr
- Subjects
Adult ,Diagnosis, Differential ,Male ,AIDS-Related Opportunistic Infections ,Alopecia Areata ,Skull ,HIV-1 ,Humans ,HIV Infections ,Syphilis ,Osteitis - Published
- 2013
7. Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients
- Author
-
Maxime Hentzien, D. Lambert, M.D. Diebold, Firouzé Bani-Sadr, C. Boulagnon, Roland Jaussaud, F. Ramaholimihaso, C. Rouger, Yohan Nguyen, Université de Reims Champagne-Ardenne (URCA), Hôpital Robert Debré, and Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)
- Subjects
medicine.medical_specialty ,biology ,business.industry ,education ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,macromolecular substances ,Chronic diarrhoea ,Helicobacter pylori ,biology.organism_classification ,Gastroenterology ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Chronic diarrhea ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Internal medicine ,medicine ,Hiv infected patients ,030211 gastroenterology & hepatology ,030212 general & internal medicine ,Gastritis ,medicine.symptom ,business - Abstract
International audience; We report 2 cases of chronic diarrhea in HIV patients with evidence of symptomatic HP gastritis; the outcome was favorable after HP eradication.
- Published
- 2014
- Full Text
- View/download PDF
8. Histoplasmose disséminée et SIDA : trois observations
- Author
-
A. Strady, J. Deville, R. Jaussaud, O. Riche, D. Puygauthier-Toubas, C. Rouger, and G. Remy
- Subjects
Gynecology ,medicine.medical_specialty ,biology ,business.industry ,biology.organism_classification ,medicine.disease ,Histoplasma capsulatum ,Histoplasmosis ,Infectious Diseases ,Disseminated histoplasmosis ,medicine ,business ,Sida ,Mycosis ,Mixed infection - Abstract
Resume Les auteurs rapportent trois cas d'histoplasmose disseminee a Histoplasma capsulatum venant reveler ou compliquer un SIDA. L'histoplasmose est une pathologie d'importation qui constitue la troisieme mycose opportuniste du SIDA et fait classer les sujets atteints dans le groupe IV C1. Le tableau clinique realise n'est pas specifique, pouvant simuler une autre infection opportuniste ou meme preter a confusion avec un lymphome. Le diagnostic positif repose sur la mise en evidence de levures d'H. capsulatum dans le sang, la moelle osseuse ou une biopsie d'organe. Le traitement d'attaque de reference est l'amphotericine B ; un traitement d'entretien est necessaire etant donne la frequence des recidives.
- Published
- 1991
- Full Text
- View/download PDF
9. Ostéite de jambe à Pleurostomaphora richardsiae et Cladophiala bantiana : à propos d’un cas après fracture ouverte de jambe
- Author
-
S. Bredin, S. Diallo, D. Toubas, G. Aparicio, and C. Rouger
- Subjects
Infectious Diseases - Published
- 2013
- Full Text
- View/download PDF
10. COL2-05 Organisation et financement d’un COREVIH
- Author
-
B. Christian, T. May, L. Boyer, C. Rouger, F. Manfait, and E. Libbrecht
- Subjects
Infectious Diseases - Abstract
Le COREVIH Lorraine-Champagne-Ardenne a ete installe en octobre 2007. Le budget etait de 300 000 euros. Il a permis l’obtention de 2,5 postes de TEC, d’une assistante administrative, d’un 0,8 PH et le financement du logiciel E-Nadis. Lors de la premiere Assemblee Generale en janvier 2008, un programme annuel a ete defini : − Mise en place d’une commission soins et epidemiologie avec comme themes de travail : recueil epidemiologique fonde sur l’activite des services et les caracteristiques de la population suivie, diffusion du logiciel E-Nadis si possible a tous les sites regionaux, reunion mensuelle d’une comite des antiretroviraux pour discuter collegialement des dossiers patients (echec, intolerance, grossesse), harmonisation regionale des procedures de prise en charge de l’hospitalisation de jour, formation des soignants a la consultation d’observance, harmonisation des procedures de suivi pour la prevention des complications metaboliques, recueil de l’incidence des nouvelles IST chez les patients suivis, recueil collectif des motifs de prise en charge tardive, redaction d’une procedure pour les perdus de vue, harmonisation des procedures de prise en charge des AES. − Mise en place d’une commission de prevention, feormation, ethique et sociale avec comme themes de travail : le renforcement des actions de prevention primaire et secondaire axees sur la place des tests rapides de depistage, le developpement des groupes de parole par le biais des associations, la reactualisation de la formation pour le personnel des CDAG, la creation d’un repertoire des difficultes sociales ou ethiques et des actions correctives. Pour chaque theme ont ete determines un responsable des objectifs, des actions, des indicateurs, une mesure d’impact et un calendrier. Un rapport d’activite sera redige annuellement et transmis aux autorites de tutelle.
- Published
- 2008
- Full Text
- View/download PDF
11. Erythema elevatum diutinum associé à un carcinome épidermoïde bronchique
- Author
-
A. Servettaz, C. Rouger, A. Strady, and Roland Jaussaud
- Subjects
Gastroenterology ,Internal Medicine - Published
- 2003
- Full Text
- View/download PDF
12. L’endocardite infectieuse en médecine interne
- Author
-
Roland Jaussaud, G. Remy, I. Beguinot, B. Kolb, J. Deville, A. Strady, C. Rouger, and A. Waldner
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1999
- Full Text
- View/download PDF
13. Fièvre hémorragique avec syndrome rénal: analyse de 34 observations
- Author
-
I Bequinot, J. Deville, C Himberlin, G. Remy, C. Rouger, A. Strady, and Roland Jaussaud
- Subjects
Gastroenterology ,Internal Medicine - Published
- 1998
- Full Text
- View/download PDF
14. III.—Les vaccinations antirabiques au centre hospitalier de reims
- Author
-
G. Rémy, C. Rouger, J. Deville, and A. Strady
- Subjects
General Medicine - Published
- 1985
- Full Text
- View/download PDF
15. Les vaccinations antirabiques en France en 1987
- Author
-
J. Deville, A. Strady, C. Rouger, and G. Rémy
- Subjects
General Medicine - Published
- 1988
- Full Text
- View/download PDF
16. Septicemie a Gardnerella vaginalis et tumeur maligne de l'ovaire chez une femme de 75 ans
- Author
-
J. Deville, G. Remy, M. Pierre, A.G. Combremont, C. Rouger, P. Girard, A. Strady, and R. Jaussaud
- Subjects
Infectious Diseases - Abstract
Resume Gardnerella vaginalis est l'un des agents des vaginites non specifiques. Il peut egalement etre responsable dans certaines circonstances d'infections septicemiques. Les auteurs rapportent ici une observation de septicemie a Gardnerella vaginalis qui fait decouvrir une tumeur maligne de l'ovaire.
- Published
- 1989
- Full Text
- View/download PDF
17. Thyroidite suppuree. A propos d'une observation
- Author
-
J. Deville, R. Jaussaud, C. Rouger, B. Depernet, J.F. Delattre, G. Remy, P. Girard, and A. Strady
- Subjects
Gynecology ,medicine.medical_specialty ,Infectious Diseases ,Philosophy ,medicine - Abstract
Resume Les auteurs rapportent une observation de thyroidite suppuree a Pneumocoques. A cette occasion, ils passent en revue les problemes etiologiques, diagnostiques, evolutifs et therapeutiques poses par ces affections.
- Published
- 1988
- Full Text
- View/download PDF
18. Les vaccinations Antirabiques au Centre Hospitalier de Reims
- Author
-
J. Deville, A. Strady, G. Rémy, and C. Rouger
- Subjects
General Medicine - Published
- 1987
- Full Text
- View/download PDF
19. III. — Les vaccinations antirabiques au Centre Hospitalier de Reims
- Author
-
A. Strady, G. Rémy, C. Rouger, and J. Deville
- Subjects
General Medicine - Published
- 1986
- Full Text
- View/download PDF
20. [Cerebral abscess and Osler-Rendu disease. Apropos of 4 cases]
- Author
-
P, Peruzzi, B, Scherpereel, C, Rouger, A, Bazin, M H, Bernard, and P, Rousseaux
- Subjects
Adult ,Male ,Adolescent ,Streptococcal Infections ,Arteriovenous Fistula ,Brain Abscess ,Humans ,Female ,Telangiectasia, Hereditary Hemorrhagic ,Middle Aged ,Staphylococcal Infections ,Lung - Abstract
The authors report 4 cases of cerebral abscesses (C.A.) complicating Rendu Osler disease (hereditary haemorrhagic telangiectasia: H.H.T.). These cases and 43 others comparable found in literature enable to assess C.A. complicates H.H.T. by the way of pulmonary arteriovenous fistulas (P.A.V.F.). C.A. appears during known H.H.T. in only a quarter of cases; in all other cases C.A. reveals the disease. When the etiological search for metastatic C.A. fails to find any classical cause: O.R.L., stomatologic, cardiac, it seems important to suspect H.H.T., and research P.A.V.F. by chest X ray and pulmonary angiography. Preventive treatment consists in excluding pulmonary fistulas without waiting neurological complications of known H.H.T.
- Published
- 1988
21. [Animal bites. Epidemiology and infection risks]
- Author
-
A, Strady, C, Rouger, V, Vernet, A G, Combremont, G, Remy, J, Deville, and C, Chippaux
- Subjects
Adult ,Male ,Adolescent ,Risk Factors ,Animals, Domestic ,Animals ,Humans ,Animals, Wild ,Female ,Bacterial Infections ,Bites and Stings ,Prospective Studies ,Child - Abstract
A review of 5,116 cases of animal bites (587 of which were studied prospectively) has shed some light on their epidemiological aspects and on the risk of infection they carry. It has also led to a more objective assessment of the real effect of the therapeutic and prophylactic measures usually applied in such cases. The most frequent wounds are those of the hands and face, the former rising an infectious problem, the latter a predominantly cosmetic problem. The overall risk of infection is 30 per cent, but it is increased, notably as regards pasteurellosis, in the case of cat bite. Precise and simple rules concerning the prevention of this risk cannot easily be given, but it seems that the systematic antibiotic treatment initially prescribed has not clearly proved effective. Similarly, early sutures do not significantly increase the risk of infection.
- Published
- 1988
22. Isolement de Yersinia enterocolitica à partir d'une phlébite suppurée
- Author
-
V. Vernet, C. Rouger, and A. Strady
- Subjects
Cellulite ,biology ,business.industry ,biology.organism_classification ,medicine.disease ,Enterobacteriaceae ,Lower limb ,Microbiology ,Long Saphenous Vein ,Infectious Diseases ,Cellulitis ,medicine ,Yersinia enterocolitica ,business - Abstract
Resume Yersinia enterocolitica a ete isolee du prelevement operatoire d'une phlebite suppuree de la veine saphene interne. Une porte d'entree cutanee possible a partir d'un ulcere variqueux chronique est envisagee.
- Published
- 1986
- Full Text
- View/download PDF
23. Septicemie a Eikenella corrodens a point de depart vesiculaire hautement probable
- Author
-
G. Remy, P. Girard, J. P. Vilque, A.G. Combremont, F. Becourt, and C. Rouger
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Gallbladder ,medicine.medical_treatment ,Eikenella corrodens ,biology.organism_classification ,Bacteroides corrodens ,medicine.disease ,Gastroenterology ,Infectious Diseases ,medicine.anatomical_structure ,Biliary tract ,Internal medicine ,Cholecystitis ,Medicine ,Cholecystectomy ,business - Abstract
resume Les auteurs rapportent un cas de septicemie a Eikenella corrodens resistant a une antibiotherapie adaptee jusqu'a la cholecystectomie.
- Published
- 1987
- Full Text
- View/download PDF
24. Septicémie à Erysipelothrix rhusiopathiae sans endocardite
- Author
-
C. Rouger, A.G. Combremont, D. Ladier, and C. Saison
- Subjects
Infectious Diseases ,biology ,business.industry ,Medicine ,Erysipelothrix rhusiopathiae ,biology.organism_classification ,business ,Molecular biology - Abstract
Resume Nous rapportons l'observation d'une septicemie a Erysipelothrix rhusiopathiae sans endocardite, survenue apres inoculation cutanee. Ce germe, surtout connu comme agent de l'erysipeloide, est rarement retrouve dans les hemocultures. Nous rapportons un echec therapeutique avec l'ampicilline, pourtant active in vitro , et nous recommandons le traitement classique : la penicilline G.
- Published
- 1986
- Full Text
- View/download PDF
25. Vaccination antirabique preventive en milieu professionnel expose suivi de l'immunite au long cours
- Author
-
M. Roumiantzeff, C. Rouger, N. Ajjan, G. Remy, M. Lienard, A. Strady, and J. Deville
- Subjects
Infectious Diseases - Published
- 1989
- Full Text
- View/download PDF
26. Targeting of Antifungal Metabolites from Grapevine Byproducts by UPLC-HRMS/MS Approaches Using Bioactivity-Based Molecular Networking.
- Author
-
Tardif C, Rouger C, Miranda J, Ahmed OS, Richard-Forget F, Atanasova V, and Waffo-Teguo P
- Subjects
- Chromatography, High Pressure Liquid, Fungicides, Industrial pharmacology, Fungicides, Industrial chemistry, Plant Diseases microbiology, Waste Products analysis, Vitis chemistry, Vitis microbiology, Fusarium drug effects, Fusarium growth & development, Tandem Mass Spectrometry, Plant Extracts pharmacology, Plant Extracts chemistry
- Abstract
This study focuses on countering Fusarium graminearum , a harmful fungal pathogen impacting cereal crops and human health through mycotoxin production. These mycotoxins, categorized as type B trichothecenes, pose significant health risks. Research explores natural alternatives to synthetic fungicides, particularly investigating phenolics in grapevine byproducts. Thirteen eco-extracts from five French grape varieties (Merlot, Cabernet Sauvignon, Sauvignon blanc, Tannat, and Artaban) exhibited substantial antifungal properties, with ten extracts displaying remarkable effects. Extracts from grapevine stems and roots notably reduced fungal growth by over 91% after five days. Through UHPLC-HRMS/MS analysis and metabolomics, the study identified potent antifungal compounds such as ampelopsin A and cyphostemmin B, among other oligomeric stilbenes. Interestingly, this approach showed that flavan-3-ols have been identified as markers for extracts that induce fungal growth. Root extracts from rootstocks, rich in oligostilbenes, demonstrated the highest antifungal activity. This research underscores grapevine byproducts' potential both as a sustainable approach to control F. graminearum and mycotoxin contamination in cereal crops and the presence of different metabolites from the cultivars of grapevine, suggesting different activities.
- Published
- 2024
- Full Text
- View/download PDF
27. Valorization of Invasive Plant Extracts against the Bispecies Biofilm Staphylococcus aureus - Candida albicans by a Bioguided Molecular Networking Screening.
- Author
-
Hamion G, Aucher W, Tardif C, Miranda J, Rouger C, Imbert C, and Girardot M
- Abstract
Invasive plants efficiently colonize non-native territories, suggesting a great production of bioactive metabolites which could be effective antibiofilm weapons. Our study aimed to look for original molecules able to inhibit bispecies biofilm formed by S. aureus and C. albicans. Extracts from five invasive macrophytes (Ludwigia peploides, Ludwigia grandiflora, Myriophyllum aquaticum, Lagarosiphon major and Egeria densa) were prepared and tested in vitro against 24 h old bispecies biofilms using a crystal violet staining (CVS) assay. The activities of the extracts reducing the biofilm total biomass by 50% or more were comparatively analyzed against each microbial species forming the biofilm by flow cytometry (FCM) and scanning electron microscopy. Extracts active against both species were fractionated. Obtained fractions were analyzed by UHPLC-MS/MS and evaluated by the CVS assay. Chemical and biological data were combined into a bioactivity-based molecular networking (BBMN) to identify active compounds. The aerial stem extract of L. grandiflora showed the highest antibiofilm activity (>50% inhibition at 50 µg∙mL−1). The biological, chemical and BBMN investigations of its fractions highlighted nine ions correlated with the antibiofilm activity. The most correlated compound, identified as betulinic acid (BA), inhibited bispecies biofilms regardless of the three tested couples of strains (ATCC strains: >40% inhibition, clinical isolates: ≈27% inhibition), confirming its antibiofilm interest.
- Published
- 2022
- Full Text
- View/download PDF
28. Naturally occurring phenolic compounds as promising antimycotoxin agents: Where are we now?
- Author
-
Ahmed OS, Tardif C, Rouger C, Atanasova V, Richard-Forget F, and Waffo-Téguo P
- Subjects
- Animals, Fungi, Food Contamination analysis, Food Contamination prevention & control, Mycotoxins analysis
- Abstract
Mycotoxins are metabolites produced by molds that contaminate food commodities, are harmful to both humans and animals, as well as cause economic losses. Many countries have set regulatory limits and strict thresholds to control the level of mycotoxins in food and feedstuffs. New technologies and strategies have been developed to inhibit toxigenic fungal invasion and to decontaminate mycotoxins. However, many of these strategies do not sufficiently detoxify mycotoxins and leave residual toxic by-products. This review focuses on the use of phenolic compounds obtained from botanical extracts as promising bioagents to inhibit fungal growth and/or to limit mycotoxin yields. The mechanism of these botanicals, legislation concerning their use, and their safety are also discussed. In addition, recent strategies to overcome stability and solubility constraints of phenolic compounds to be used in food and feed stuffs are also mentioned., (© 2022 Institute of Food Technologists®.)
- Published
- 2022
- Full Text
- View/download PDF
29. In Vivo Genotoxicity Evaluation of a Stilbene Extract Prior to Its Use as a Natural Additive: A Combination of the Micronucleus Test and the Comet Assay.
- Author
-
Medrano-Padial C, Puerto M, Prieto AI, Ayala N, Beaumont P, Rouger C, Krisa S, and Pichardo S
- Abstract
Genotoxic data of substances that could be used as food additives are required by the European Food Safety Authority. In this sense, the use of an extract from grapevine shoots containing a stilbene richness of 99% (ST-99), due to its antioxidant and antibacterial activities, has been proposed as an alternative to sulfur dioxide in wine. The aim of this work was to study, for the first time, the in vivo genotoxic effects produced in rats orally exposed to 90, 180, or 360 mg ST-99/kg body weight at 0, 24, and 45 h. The combination of micronucleus assay in bone marrow (OECD 474) and standard (OECD 489) and enzyme-modified comet assay was used to determine the genotoxicity on cells isolated from stomach, liver, and blood of exposed animals. The ST-99 revealed no in vivo genotoxicity. These results were corroborated by analytical studies that confirm the presence of stilbenes and their metabolites in plasma and tissues. Moreover, to complete these findings, a histopathological study was performed under light microscopy in liver and stomach showing only slight modifications in both organs at the highest concentration used. The present work confirms that this extract is not genotoxic presenting a good profile for its potential application as a preservative in the wine industry.
- Published
- 2021
- Full Text
- View/download PDF
30. Bromotryptamine and Imidazole Alkaloids with Anti-inflammatory Activity from the Bryozoan Flustra foliacea .
- Author
-
Di X, Wang S, Oskarsson JT, Rouger C, Tasdemir D, Hardardottir I, Freysdottir J, Wang X, Molinski TF, and Omarsdottir S
- Subjects
- Alkaloids chemistry, Animals, Anti-Inflammatory Agents chemistry, Alkaloids metabolism, Anti-Inflammatory Agents metabolism, Bryozoa chemistry, Imidazoles metabolism, Tryptamines metabolism
- Abstract
Chemical investigation of the marine bryozoan Flustra foliacea collected in Iceland resulted in isolation of 13 new bromotryptamine alkaloids, flustramines Q-W ( 1 - 7 ) and flustraminols C-H ( 8 - 13 ), and two new imidazole alkaloids, flustrimidazoles A and B ( 14 and 15 ), together with 12 previously described compounds ( 16 - 27 ). Their structures were established by detailed spectroscopic analysis using 1D and 2D NMR and HRESIMS. Structure 2 was verified by calculations of the
13 C and1 H NMR chemical shifts using density functional theory. The relative and absolute configurations of the new compounds were elucidated on the basis of coupling constant analysis, NOESY, [α]D , and ECD spectroscopic data, in addition to chemical derivatization. The compounds were tested for in vitro anti-inflammatory activity using a dendritic cell model. Eight compounds ( 1 , 3 , 5 , 13 , 16 , 18 , 26 , and 27 ) decreased dendritic cell secretion of the pro-inflammatory cytokine IL-12p40, and two compounds ( 4 and 14 ) increased secretion of the anti-inflammatory cytokine IL-10. Deformylflustrabromine B ( 27 ) showed the most potent anti-inflammatory effect (IC50 2.9 μM). These results demonstrate that F. foliacea from Iceland expresses a broad range of brominated alkaloids, many without structural precedents. The potent anti-inflammatory activity in vitro of metabolite 27 warrants further investigations into its potential as a lead for inflammation-related diseases.- Published
- 2020
- Full Text
- View/download PDF
31. Targeting MHC Regulation Using Polycyclic Polyprenylated Acylphloroglucinols Isolated from Garcinia bancana .
- Author
-
Coste C, Gérard N, Dinh CP, Bruguière A, Rouger C, Leong ST, Awang K, Richomme P, Derbré S, and Charreau B
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 2 metabolism, Acylation, Benzophenones chemistry, Benzophenones isolation & purification, Benzophenones pharmacology, Down-Regulation drug effects, Endothelial Cells drug effects, GATA2 Transcription Factor metabolism, Humans, Interferon-gamma metabolism, Major Histocompatibility Complex drug effects, Major Histocompatibility Complex genetics, Membrane Transport Proteins metabolism, Molecular Docking Simulation, Nuclear Proteins metabolism, Phloroglucinol chemistry, Phloroglucinol isolation & purification, Polycyclic Compounds chemistry, Polycyclic Compounds isolation & purification, Prenylation, Primary Cell Culture, STAT1 Transcription Factor metabolism, Terpenes chemistry, Terpenes pharmacology, Trans-Activators metabolism, p300-CBP Transcription Factors antagonists & inhibitors, p300-CBP Transcription Factors chemistry, Garcinia chemistry, Phloroglucinol analogs & derivatives, Phloroglucinol pharmacology, Polycyclic Compounds pharmacology
- Abstract
Modulation of major histocompatibility complex (MHC) expression using drugs has been proposed to control immunity. Phytochemical investigations on Garcinia species have allowed the isolation of bioactive compounds such as polycyclic polyprenylated acylphloroglucinols (PPAPs). PPAPs such as guttiferone J ( 1 ), display anti-inflammatory and immunoregulatory activities while garcinol ( 4 ) is a histone acetyltransferases (HAT) p300 inhibitor. This study reports on the isolation, identification and biological characterization of two other PPAPs, i.e., xanthochymol ( 2 ) and guttiferone F ( 3 ) from Garcinia bancana , sharing structural analogy with guttiferone J ( 1 ) and garcinol ( 4 ). We show that PPAPs 1 - 4 efficiently downregulated the expression of several MHC molecules (HLA-class I, -class II, MICA/B and HLA-E) at the surface of human primary endothelial cells upon inflammation. Mechanistically, PPAPs 1 - 4 reduce MHC proteins by decreasing the expression and phosphorylation of the transcription factor STAT1 involved in MHC upregulation mediated by IFN-γ. Loss of STAT1 activity results from inhibition of HAT CBP/p300 activity reflected by a hypoacetylation state. The binding interactions to p300 were confirmed through molecular docking. Loss of STAT1 impairs the expression of CIITA and GATA2 but also TAP1 and Tapasin required for peptide loading and transport of MHC. Overall, we identified new PPAPs issued from Garcinia bancana with potential immunoregulatory properties.
- Published
- 2020
- Full Text
- View/download PDF
32. Chemistry, bioactivity and biosynthesis of cyanobacterial alkylresorcinols.
- Author
-
Martins TP, Rouger C, Glasser NR, Freitas S, de Fraissinette NB, Balskus EP, Tasdemir D, and Leão PN
- Subjects
- Cyanobacteria genetics, Molecular Structure, Multigene Family, Resorcinols metabolism, Cyanobacteria metabolism, Resorcinols chemistry, Resorcinols pharmacology
- Abstract
Covering: up to 2019 Alkylresorcinols are amphiphilic metabolites, well-known for their diverse biological activities, produced by both prokaryotes and eukaryotes. A few classes of alkylresorcinol scaffolds have been reported from the photoautotrophic cyanobacteria, ranging from the relatively simple hierridins to the more intricate cylindrocyclophanes. Recently, it has emerged that cyanobacteria employ two different biosynthetic pathways to produce unique alkylresorcinol scaffolds. However, these convergent pathways intersect by sharing biosynthetic elements which lead to common structural motifs. To obtain a broader view of the biochemical diversity of these compounds in cyanobacteria, we comprehensively cover the isolation, structure, biological activity and biosynthesis of their mono- and dialkylresorcinols. Moreover, we provide an overview of the diversity and distribution of alkylresorcinol-generating biosynthetic gene clusters in this phylum and highlight opportunities for discovery of novel alkylresorcinol scaffolds. Because some of these molecules have inspired notable syntheses, different approaches used to build these molecules in the laboratory are showcased.
- Published
- 2019
- Full Text
- View/download PDF
33. Seasonal Variations in the Metabolome and Bioactivity Profile of Fucus vesiculosus Extracted by an Optimised, Pressurised Liquid Extraction Protocol.
- Author
-
Heavisides E, Rouger C, Reichel AF, Ulrich C, Wenzel-Storjohann A, Sebens S, and Tasdemir D
- Subjects
- A549 Cells, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents metabolism, Anti-Bacterial Agents pharmacology, Antineoplastic Agents, Phytogenic chemistry, Antineoplastic Agents, Phytogenic isolation & purification, Antineoplastic Agents, Phytogenic metabolism, Antineoplastic Agents, Phytogenic pharmacology, Biological Products chemistry, Biological Products isolation & purification, Biological Products metabolism, Biological Products pharmacology, Chromatography, High Pressure Liquid instrumentation, Chromatography, High Pressure Liquid methods, Drug Screening Assays, Antitumor, Free Radical Scavengers chemistry, Free Radical Scavengers isolation & purification, Free Radical Scavengers metabolism, Free Radical Scavengers pharmacology, Fucus chemistry, Humans, Liquid-Liquid Extraction instrumentation, Liquid-Liquid Extraction methods, Metabolomics instrumentation, Metabolomics methods, Methicillin-Resistant Staphylococcus aureus drug effects, Microbial Sensitivity Tests, Plant Extracts chemistry, Plant Extracts isolation & purification, Pressure, Seaweed chemistry, Fucus metabolism, Metabolome, Plant Extracts pharmacology, Seasons, Seaweed metabolism
- Abstract
The metabolism of seaweeds depends on environmental parameters, the availability of nutrients, and biotic/abiotic stresses; therefore, their chemical composition fluctuates throughout the year. This study investigated seasonal variations in the metabolome of the Baltic Sea brown alga Fucus vesiculosus and its potential relation to the bioactivity profile. By using a definitive screening design (DSD) combined with pressurised liquid extraction (PLE), an optimised protocol was developed to extract algal biomass monthly for a full calendar year. An untargeted metabolomics approach using ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS
n )-based molecular networking and manual dereplication was employed. The extracts were simultaneously screened for their in vitro antimicrobial, anticancer/apoptotic, and free radical scavenging activities. 44 compounds were putatively dereplicated in the metabolome. Many compounds were found to vary with the sampling month; phlorotannin total ion count (TIC) was highest in summer, whilst chlorophylls, lipids, and carotenoids peaked in winter and spring. The greatest radical scavenging and apoptotic activities against pancreas cancer cells observed in the summer months were attributed to high phlorotannin TIC. Methicillin-resistant Staphylococcus aureus (MRSA) inhibitory activity was produced year-round without a clear seasonal trend. This is the first study applying DSD-based optimised PLE extraction combined with a metabolome analysis of F. vesiculosus for the identification of seasonal variations in both metabolome and bioactivity.- Published
- 2018
- Full Text
- View/download PDF
34. 6-Bromoindole Derivatives from the Icelandic Marine Sponge Geodia barretti : Isolation and Anti-Inflammatory Activity.
- Author
-
Di X, Rouger C, Hardardottir I, Freysdottir J, Molinski TF, Tasdemir D, and Omarsdottir S
- Subjects
- Alkaloids chemistry, Alkaloids isolation & purification, Animals, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents isolation & purification, CD4-Positive T-Lymphocytes drug effects, CD4-Positive T-Lymphocytes metabolism, Cell Differentiation drug effects, Cells, Cultured, Coculture Techniques, Dendritic Cells, Humans, Iceland, Indoles chemistry, Inhibitory Concentration 50, Interleukin-10 metabolism, Interleukin-12 Subunit p40 metabolism, Peptides, Cyclic chemistry, Peptides, Cyclic isolation & purification, Stereoisomerism, Alkaloids pharmacology, Anti-Inflammatory Agents pharmacology, Aquatic Organisms, Geodia, Peptides, Cyclic pharmacology
- Abstract
An UPLC-qTOF-MS-based dereplication study led to the targeted isolation of seven bromoindole alkaloids from the sub-Arctic sponge Geodia barretti . This includes three new metabolites, namely geobarrettin A⁻C ( 1 ⁻ 3 ) and four known compounds, barettin ( 4 ), 8,9-dihydrobarettin ( 5 ), 6-bromoconicamin ( 6 ), and l-6-bromohypaphorine ( 7 ) . The chemical structures of compounds 1 ⁻ 7 were elucidated by extensive analysis of the NMR and HRESIMS data. The absolute stereochemistry of geobarrettin A ( 1 ) was assigned by ECD analysis and Marfey's method employing the new reagent l- N
α -(1-fluoro-2,4-dinitrophenyl)tryptophanamide (l-FDTA). The isolated compounds were screened for anti-inflammatory activity using human dendritic cells (DCs). Both 2 and 3 reduced DC secretion of IL-12p40, but 3 concomitantly increased IL-10 production. Maturing DCs treated with 2 or 3 before co-culturing with allogeneic CD4⁺ T cells decreased T cell secretion of IFN-γ, indicating a reduction in Th1 differentiation. Although barettin ( 4 ) reduced DC secretion of IL-12p40 and IL-10 (IC50 values 11.8 and 21.0 μM for IL-10 and IL-12p40, respectively), maturing DCs in the presence of 4 did not affect the ability of T cells to secrete IFN-γ or IL-17, but reduced their secretion of IL-10. These results indicate that 2 and 3 may be useful for the treatment of inflammation, mainly of the Th1 type.- Published
- 2018
- Full Text
- View/download PDF
35. In vivo characterization of bivalve larval shells: a confocal Raman microscopy study.
- Author
-
Ramesh K, Melzner F, Griffith AW, Gobler CJ, Rouger C, Tasdemir D, and Nehrke G
- Subjects
- Animals, Bivalvia anatomy & histology, Bivalvia chemistry, Bivalvia growth & development, Calcification, Physiologic, Calcium Carbonate chemistry, Larva chemistry, Microscopy, Confocal, Mytilus anatomy & histology, Mytilus growth & development, Spectroscopy, Fourier Transform Infrared, Animal Shells chemistry, Calcium Carbonate analysis, Mytilus chemistry
- Abstract
In vivo confocal Raman microscopy (CRM), polarized light microscopy and Fourier transform infrared spectroscopy (FTIR) were used to determine if a significant amount of amorphous calcium carbonate (ACC) exists within larval shells of Baltic mytilid mussels ( Mytilus edulis -like) and whether the amount of ACC varies during larval development. No evidence for ACC was found from the onset of shell deposition at 21 h post-fertilization (hpf) until 48 hpf. Larval Mytilus shells were crystalline from 21 hpf onwards and exhibited CRM and FTIR peaks characteristic of aragonite. Prior to shell deposition at 21 hpf, no evidence for carbonates was observed through in vivo CRM. We further analysed the composition of larval shells in three other bivalve species, Mercenaria mercenaria , Crassostrea gigas and Crassostrea virginica and observed no evidence for ACC, which is in contrast to previous work on the same species. Our findings indicate that larval bivalve shells are composed of crystalline aragonite and we demonstrate that conflicting results are related to sub-optimal measurements and misinterpretation of CRM spectra. Our results demonstrate that the common perception that ACC generally occurs as a stable and abundant precursor during larval bivalve calcification needs to be critically reviewed., (© 2018 The Author(s).)
- Published
- 2018
- Full Text
- View/download PDF
36. Factors Associated with Geophagy and Knowledge About Its Harmful Effects Among Native Sub-Saharan African, Caribbean and French Guiana HIV Patients Living in Northern France.
- Author
-
Kmiec I, Nguyen Y, Rouger C, Berger JL, Lambert D, Hentzien M, Lebrun D, Robbins A, Drame M, and Bani-Sadr F
- Subjects
- Adult, Africa South of the Sahara ethnology, Anemia, Iron-Deficiency epidemiology, Caribbean Region ethnology, Ethnicity, Feeding and Eating Disorders, Female, France epidemiology, French Guiana ethnology, Humans, Male, Prevalence, Anemia, Iron-Deficiency complications, HIV Infections complications, Health Knowledge, Attitudes, Practice, Pica complications, Soil
- Abstract
Geophagy, or the ingestion of earth or clay, is widespread among women of Sub-Saharan African, Caribbean or French Guiana origin. Little is known about this practice among HIV patients native of these countries and who are followed-up in France. The aims of this study were to determine (i) the prevalence and factors associated with geophagy among HIV patients native of these countries, (ii) patients' knowledge about the harmful effects of geophagy, and (iii) the association of geophagy with iron deficiency, or a history of anemia or constipation. Among the 119 included patients, current geophagy and previous geophagy were present in 11/119 (9%) and 47/119 (40%) patients, respectively. Female gender was the only factor associated with consumption (OR 5.37; 95% CI 2.07-15.92 p = 0.001). Awareness about the risk of iron-deficient anemia was low (24%). Preventive education should be integrated into the care of HIV adults from countries in which geophagy is a culture and widely accepted practice.
- Published
- 2017
- Full Text
- View/download PDF
37. Prenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial Cells.
- Author
-
Rouger C, Pagie S, Derbré S, Le Ray AM, Richomme P, and Charreau B
- Subjects
- Antigen Presentation drug effects, Biological Products chemistry, Clusiaceae chemistry, Coumarins pharmacology, Cytokines biosynthesis, E-Selectin biosynthesis, Endothelial Cells pathology, Histocompatibility Antigens Class II biosynthesis, Humans, Inflammation genetics, Inflammation pathology, Intercellular Adhesion Molecule-1 biosynthesis, Interferon-gamma biosynthesis, Polyphenols chemistry, Prenylation drug effects, Tumor Necrosis Factor-alpha biosynthesis, Vascular Cell Adhesion Molecule-1 biosynthesis, Biological Products pharmacology, Endothelial Cells drug effects, Inflammation drug therapy, Polyphenols pharmacology
- Abstract
Endothelial cells (ECs) are key players in inflammation and immune responses involved in numerous pathologies. Although attempts were experimentally undertaken to prevent and control EC activation, drug leads and probes still remain necessary. Natural products (NPs) from Clusiaceous and Calophyllaceous plants were previously reported as potential candidates to prevent endothelial dysfunction. The present study aimed to identify more precisely the molecular scaffolds that could limit EC activation. Here, 13 polyphenols belonging to 5 different chemical types of secondary metabolites (i.e., mammea coumarins, a biflavonoid, a pyranochromanone acid, a polyprenylated polycyclic acylphloroglucinol (PPAP) and two xanthones) were tested on resting and cytokine-activated EC cultures. Quantitative and qualitative changes in the expression of both adhesion molecules (VCAM-1, ICAM-1, E-selectin) and major histocompatibility complex (MHC) molecules have been used to measure their pharmaceutical potential. As a result, we identified 3 mammea coumarins that efficiently reduce (up to >90% at 10 μM) both basal and cytokine-regulated levels of MHC class I, class II, MICA and HLA-E on EC surface. They also prevented VCAM-1 induction upon inflammation. From a structural point of view, our results associate the loss of the free prenyl group substituting mammea coumarins with a reduced cellular cytotoxicity but also an abrogation of their anti-inflammatory potential and a reduction of their immunosuppressive effects. A PPAP, guttiferone J, also triggers a strong immunomodulation but restricted to HLA-E and MHC class II molecules. In conclusion, mammea coumarins with a free prenyl group and the PPAP guttiferone J emerge as NPs able to drastically decrease both VCAM-1 and a set of MHC molecules and to potentially reduce the immunogenicity of the endothelium., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
38. Identification of Minor Benzoylated 4-Phenylcoumarins from a Mammea neurophylla Bark Extract.
- Author
-
Dang BT, Rouger C, Litaudon M, Richomme P, Séraphin D, and Derbré S
- Subjects
- Molecular Structure, Nuclear Magnetic Resonance, Biomolecular, Coumarins chemistry, Mammea chemistry, Plant Bark chemistry, Plant Extracts chemistry
- Abstract
Through dereplication analysis, seven known Mammea coumarins were identified in a fraction obtained from Mammea neurophylla dichloromethane bark extract selected for its ability to prevent advanced glycation end-product (AGE) formation. Among them, a careful examination of the NMR dataset of pedilanthocoumarin B led to a structural revision. Inspection of LC-DAD-MS(n) chromatograms allowed us to predict the presence of four new compounds, which were further isolated. Using spectroscopic methods (¹H-, (13)C- and 2D-NMR, HRMS, UV), these compounds were identified as new benzoyl substituted 4-phenylcoumarins (iso-pedilanthocoumarin B and neurophyllol C) and 4-(1-acetoxypropyl)coumarins cyclo F (ochrocarpins H and I).
- Published
- 2015
- Full Text
- View/download PDF
39. Lepidotol A from Mesua lepidota Inhibits Inflammatory and Immune Mediators in Human Endothelial Cells.
- Author
-
Rouger C, Derbré S, Charreau B, Pabois A, Cauchy T, Litaudon M, Awang K, and Richomme P
- Subjects
- Anti-Inflammatory Agents pharmacology, Cell Adhesion drug effects, Coumarins chemistry, Endothelial Cells drug effects, Fruit chemistry, Humans, Immunologic Factors pharmacology, Inflammation metabolism, Intercellular Adhesion Molecule-1 metabolism, Molecular Structure, NF-kappa B metabolism, Tumor Necrosis Factor-alpha, Vascular Cell Adhesion Molecule-1, Coumarins isolation & purification, Coumarins pharmacology, Endothelial Cells metabolism, Malpighiaceae chemistry
- Abstract
Phytochemical investigation on the fruits of Mesua lepidota (Calophyllaceae) led to the isolation of seven new phenylcoumarin derivatives named lepidotols A-E (1-5) and lepidotins A and B (6, 7). These structures were elucidated by spectroscopic and spectrometric methods including UV, NMR, and HRMS. Lepidotol A (1), the major compound, was evaluated for its inhibitory effect on inflammation and immunity using endothelial cell-based cellular assays. At 10 μM, 1 exhibited an anti-inflammatory activity, with a significant inhibition of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 expression induced by tumor necrosis factor-α. Lepidotol A also showed a mild immunosuppressive effect, with inhibition of the major histocompatibility complex molecules, namely, human leukocyte antigen (HLA)-DR and HLA-E.
- Published
- 2015
- Full Text
- View/download PDF
40. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.
- Author
-
Lambert D, Dramé M, Rouger C, Brodard V, Nguyen Y, Berger JL, Kmiec I, Hentzien M, Lebrun D, Jaussaud R, Andreoletti L, and Bani-Sadr F
- Subjects
- Adult, CD4 Lymphocyte Count, Female, France epidemiology, HIV-1, Humans, Immunity, Humoral, Male, Middle Aged, Odds Ratio, Prevalence, Risk Factors, Antibodies, Viral blood, HIV Infections epidemiology, Measles epidemiology, Vaccination statistics & numerical data
- Abstract
We investigated measles humoral immunity levels in a cohort of HIV-infected adult patients in France and attempted to identify risk factors for antimeasles antibodies seronegativity. Being born after 1983 [odds ratio (OR) 4.40; 95% confidence interval (95% CI) 1.26-14.09; P = 0.0013] and a nadir CD4⁺ cell count below 100 cells/μl (OR 4.79; 95% CI 1.61-14.82; P = 0.0048) were the two factors independently associated with measles seronegativity. Systematic measles antibody screening should be performed in HIV-infected individuals born in the era of measles vaccination (after 1983 in France).
- Published
- 2015
- Full Text
- View/download PDF
41. Advanced glycation inhibition and protection against endothelial dysfunction induced by coumarins and procyanidins from Mammea neurophylla.
- Author
-
Dang BT, Gény C, Blanchard P, Rouger C, Tonnerre P, Charreau B, Rakolomalala G, Randriamboavonjy JI, Loirand G, Pacaud P, Litaudon M, Richomme P, Séraphin D, and Derbré S
- Subjects
- Animals, Antineoplastic Agents, Phytogenic chemistry, Antineoplastic Agents, Phytogenic isolation & purification, Biflavonoids chemistry, Biflavonoids isolation & purification, Catechin chemistry, Catechin isolation & purification, Cell Survival drug effects, Coumarins chemistry, Coumarins isolation & purification, Endothelial Cells, Fruit chemistry, Male, Molecular Structure, Pentacyclic Triterpenes, Plant Bark chemistry, Plant Extracts chemistry, Plant Extracts isolation & purification, Plant Leaves chemistry, Proanthocyanidins chemistry, Proanthocyanidins isolation & purification, Rats, Rats, Wistar, Triterpenes chemistry, Triterpenes isolation & purification, Triterpenes pharmacology, Xanthones chemistry, Xanthones isolation & purification, Xanthones pharmacology, Betulinic Acid, Antineoplastic Agents, Phytogenic pharmacology, Biflavonoids pharmacology, Catechin pharmacology, Coumarins pharmacology, Glycation End Products, Advanced drug effects, Mammea chemistry, Plant Extracts pharmacology, Proanthocyanidins pharmacology
- Abstract
Advanced glycation end-products (AGEs) are associated with many pathogenic disorders such as pathogenesis of diabetes or endothelial dysfunction leading to cardiovascular events. Therefore, the identification of new anti-AGE molecules or extracts aims at preventing such pathologies. Many Clusiaceae and Calophyllaceae species are used in traditional medicines to treat arterial hypertension as well as diabetes. Focusing on these plant families, an anti-AGE plant screening allowed us to select Mammea neurophylla for further phytochemical and biological studies. Indeed, both DCM and MeOH stem bark extracts demonstrated in vitro their ability to prevent inflammation in endothelial cells and to reduce vasoconstriction. A bioguided fractionation of these extracts allowed us to point out 4-phenyl- and 4-(1-acetoxypropyl)coumarins and procyanidins as potent inhibitors of AGE formation, potentially preventing endothelial dysfunction. The fractionation steps also led to the isolation of two new compounds, namely neurophyllols A and B from the DCM bark extract together with thirteen known mammea A and E coumarins (mammea A/AA, mammea A/AB, mammea A/BA, mammea A/BB, mammea A/AA cycloD, mammea A/AB cycloD, disparinol B, mammea A/AB cycloE, ochrocarpin A, mammea A/AA cycloF, mammea A/AB cycloF, mammea E/BA, mammea E/BB) as well as δ-tocotrienol, xanthones (1-hydroxy-7-methoxyxanthone, 2-hydroxyxanthone) and triterpenes (friedelin and betulinic acid). During this study, R,S-asperphenamate, previously described from fungal origin was also purified., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
42. [A false alopecia areata].
- Author
-
Rouger C, N'Guyen Y, and Bani-Sadr F
- Subjects
- AIDS-Related Opportunistic Infections complications, AIDS-Related Opportunistic Infections diagnosis, Adult, Diagnosis, Differential, HIV Infections complications, HIV-1, Humans, Male, Alopecia Areata diagnosis, Alopecia Areata etiology, Osteitis diagnosis, Osteitis etiology, Skull, Syphilis complications, Syphilis diagnosis
- Published
- 2014
- Full Text
- View/download PDF
43. Isoquinolines from the roots of Thalictrum flavum L. and their evaluation as antiparasitic compounds.
- Author
-
Ropivia J, Derbré S, Rouger C, Pagniez F, Le Pape P, and Richomme P
- Subjects
- Alkaloids isolation & purification, Alkaloids pharmacology, Antiparasitic Agents pharmacology, Benzylisoquinolines isolation & purification, Benzylisoquinolines pharmacology, Berberine isolation & purification, Berberine pharmacology, Isoquinolines isolation & purification, Plant Roots chemistry, Antiparasitic Agents isolation & purification, Isoquinolines pharmacology, Leishmania major drug effects, Thalictrum chemistry
- Abstract
Alkaloids from Thalictrum flavum L. (Ranuculaceae) growing in the Loire valley (France) were isolated and evaluated for their antiplasmodial and leishmanicidal activities. Berberine was identified as a major component but its analogue, pseudoberberine, was isolated for the first time from this plant. As far as bisbenzylisoquinolines are concerned, thalfoetidine was also isolated and, besides, its nor- derivative, northalfoetidine, was identified as a new compound. Previously isolated alkaloids from Thalictrum species such as northalidasine, northalrugosidine, thaligosidine, thalicberine, thaliglucinone, preocoteine, O-methylcassythine and armepavine were newly described in the roots of T. flavum. Tertiary isoquinolines, and particularly bisbenzylisoquinolines, were found to be leishmanicidal against L. major. Thalfoetidine appeared as the most potent but its new nor- derivative northalfoetidine, as well as northalidasine, were of particular interest due to the fact that their potential leishmanicidal activity was not associated to a strong cytotoxicity.
- Published
- 2010
- Full Text
- View/download PDF
44. High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.
- Author
-
Andréoletti L, Piednoir E, Legoff J, Brodard V, Beguinot I, Strady C, Rouger C, Piketty C, Si-Mohamed A, Kazatchkine MD, Malkin JE, and Bélec L
- Subjects
- Acquired Immunodeficiency Syndrome complications, Adult, Aged, Female, Herpes Genitalis etiology, Herpes Genitalis transmission, Humans, Male, Middle Aged, Outpatients, Seroepidemiologic Studies, Sexual Behavior, Acquired Immunodeficiency Syndrome virology, Antibodies, Viral blood, HIV-1, Herpes Genitalis epidemiology
- Abstract
Using commercially available herpes simplex virus (HSV) type-specific serological diagnostic tests, HSV type 2 (HSV-2) antibody prevalence was assessed in two parallel prospective studies including 534 human immunodeficiency virus type 1 (HIV-1)-infected outpatients living in two areas of northern France. In the first cohort of 434 subjects, 223 (51%) individuals demonstrated a positive HSV-2 serological status while 66 (66%) of 100 subjects in the second cohort were seropositive for HSV-2 (51 versus 66%; P = 0.08). Among the 223 HSV-2-seropositive subjects identified in the first study cohort, only 22 (10%) had suffered from recurrent anogenital lesions during the past 12 months while 154 (69%) had no clinical history of herpesvirus infection. Our findings demonstrate high proportions of subclinical and undiagnosed HSV-2 infection in HIV-1-infected individuals and suggest that HSV type-specific serological testing in the French HIV-1-infected subpopulation could be an efficient strategy to diagnose clinically asymptomatic HSV-2 infections.
- Published
- 2005
- Full Text
- View/download PDF
45. Prevalence of detection and dynamics of selection and reversion of K65R mutation in nucleoside reverse transcriptase inhibitor-experienced patients failing an antiretroviral regimen.
- Author
-
Brodard V, Moret H, Béguinot I, Morcrette L, Bourdaire L, Jacques J, Rouger C, Strady C, Berger JL, and Andréoletti L
- Subjects
- CD4 Lymphocyte Count, Drug Therapy, Combination, Genotype, HIV-1 isolation & purification, Humans, Mutation, Missense, Treatment Failure, Viral Load, Amino Acid Substitution, HIV Infections drug therapy, RNA-Directed DNA Polymerase genetics, Reverse Transcriptase Inhibitors therapeutic use
- Published
- 2005
46. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy.
- Author
-
Molia AC, Strady C, Rouger C, Beguinot IM, Berger JL, and Trenque TC
- Subjects
- Adult, Female, Femur Head Necrosis chemically induced, Femur Head Necrosis drug therapy, Femur Head Necrosis etiology, HIV Infections drug therapy, Humans, Male, Middle Aged, Osteonecrosis chemically induced, Osteonecrosis diagnosis, Retrospective Studies, Risk Factors, Antiretroviral Therapy, Highly Active adverse effects, HIV Infections complications, Osteonecrosis etiology
- Abstract
Objective: To report 6 cases of osteonecrosis in HIV-infected patients treated with highly active antiretroviral therapy (HAART) and compare the observed risk factors with those of published cases., Case Summaries: Osteonecrosis was diagnosed between 1999 and 2002 in 6 of 417 HIV-infected patients in our department of infectious diseases. At the time of diagnosis, mean patient age was 42 years, and 5 patients had developed AIDS. Mean CD4+ lymphocyte count was 563.5 cells/mm(3) and viral load was undetectable (<50 copies/mL) in 5 patients. The patients' mean body mass index was 22.5 kg/m(2). Four had lipodystrophy. All were receiving HAART, including a protease inhibitor in 4 patients; the remaining 2 patients had a history of protease inhibitor treatment. Median time from the first antiretroviral therapy to osteonecrosis diagnosis was 46.5 months. Established risk factors were the use of corticosteroids in 2 patients and dyslipidemia in all patients. All of the patients developed pain and functional impotence of the hip or ankle joints. Osteonecrosis of the hip was bilateral in 4 cases. Three patients required surgical intervention, all of whom had favorable outcomes., Discussion: HIV-infected patients are at a higher risk for the development of osteonecrosis and are more likely to be exposed to predisposing factors to its development. The HAART implication as a predisposing factor remains controversial., Conclusions: The pathogenesis of osteonecrosis in HIV-infected individuals may be multifactorial; the reasonable approach for clinicians consists of treating concomitant predisposing conditions that might further cause osteonecrosis.
- Published
- 2004
- Full Text
- View/download PDF
47. [Diagnostic value of clinical signs in giant cell arteritis: analysis of 415 temporal artery biopsy findings].
- Author
-
Strady C, Arav E, Strady A, Jaussaud R, Beguinot I, Rouger C, Pluot M, and Remy G
- Subjects
- Aged, Aged, 80 and over, Biopsy, Female, Giant Cell Arteritis complications, Giant Cell Arteritis pathology, Humans, Logistic Models, Male, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Giant Cell Arteritis diagnosis, Temporal Arteries pathology
- Abstract
Aim of the Study: The American College of Rheumatology (ACR) has proposed a list of criteria for diagnosis of giant cell arteritis in order to guide clinical research by differentiating it from other vasculitis. The aim of this retrospective investigation, based on the findings of 415 temporal artery biopsies was to assess the diagnostic value of these criteria in the daily clinical setting., Methods: The demographic, clinical and biological characteristics of patients with positive (confirmed cases of giant cell arteritis) or negative (controls) histopathological temporal artery biopsy findings were analyzed using downward step-by-step logistic regression analysis. This analysis enabled investigators to list signs with inherent diagnostic value. Based their odds-ratio, these factors were used to determine a clinical score for giant cell arteritis., Results: A score of over 7 - out of a maximum score of 32 - enables the diagnosis for giant cell arteritis with the best possible compromise between a sensitivity of 75.7% and a specificity of 72.2%. ACR criteria had a sensitivity of 97.5% and a specificity of 78.9% when used in our patient group., Conclusion: Our study results are original in that the control group was composed of patients in whom the diagnosis of giant cell arteritis had been suggested but refuted by the absence of histopathological findings on the temporal artery biopsy. This pragmatic attitude in selecting the control group may explain the difference observed with the ACR criteria in terms of sensitivity and specificity. Further research is needed to develop a diagnostic method for giant cell arteritis without resorting to temporal artery biopsy.
- Published
- 2002
48. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
- Author
-
Witthuhn F, Toubas D, Béguinot I, Aubert D, Rouger C, Remy G, and Pinon JM
- Subjects
- AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections microbiology, Antifungal Agents therapeutic use, Candida drug effects, Candida isolation & purification, Candida albicans drug effects, Candidiasis complications, Candidiasis diagnosis, Fluconazole therapeutic use, Humans, Itraconazole therapeutic use, Microbial Sensitivity Tests, Mycology methods, Reagent Kits, Diagnostic, Sensitivity and Specificity, AIDS-Related Opportunistic Infections drug therapy, Antifungal Agents pharmacology, Candida classification, Candidiasis drug therapy, Fluconazole pharmacology, Itraconazole pharmacology
- Abstract
One hundred eighteen Candida clinical isolates from human immunodeficiency virus-infected patients were tested for their susceptibilities to fluconazole and itraconazole by Fungitest and the National Committee for Clinical Laboratory Standards MIC method. Fungitest results depended on both yeast species and antifungal agents. This test is able to detect sensitive strains (97% agreement with results of the MIC method in tests with fluconazole and 84% agreement in tests with itraconazole) but has a poor capacity to detect resistant strains (26% agreement in tests with fluconazole and 5% agreement in tests with itraconazole).
- Published
- 1999
- Full Text
- View/download PDF
49. Adhesive capsulitis of the shoulder induced by protease inhibitor therapy. Three new cases.
- Author
-
Léone J, Béguinot I, Dehlinger V, Jaussaud R, Rouger C, Strady C, Pennaforte JL, and Etienne JC
- Subjects
- Adult, Drug Therapy, Combination, Female, HIV Infections drug therapy, Humans, Indinavir adverse effects, Lamivudine adverse effects, Male, Middle Aged, Stavudine adverse effects, Bursitis chemically induced, HIV Protease Inhibitors adverse effects, Shoulder Joint drug effects
- Published
- 1998
50. [Plurimicrobial meningitis in adults associated with asymptomatic spondylodiscitis. An uncommon manifestation of sigmoid tumor].
- Author
-
Jaussaud R, Beguinot I, Rouger C, Remy G, Strady A, and Deville J
- Subjects
- Aged, Female, Humans, Discitis etiology, Meningitis, Bacterial etiology, Sigmoid Neoplasms complications
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.